Skip to content
Abierto

Award notice

Cost Per Reportable Result Reagents, Controls and Consumables for Coagulation Testing at Naval Hospital Twentynine Palms

HT941024F0143

Defense Health Agency (Dha), Defense Health Agency HCD West. In-Vitro Diagnostic Substance Manufacturing.

Awarded

Werfen USA LLC

$50,489.84 on the award notice, August 29, 2024, contract V797D30108

Description

As published on SAM.gov.

Firm-fixed price, sole source contract of reagents and consumables supplies to perform coagulation testing at Naval Hospital Twentynine Palms in California. The lease of two coagulation analyzer, training, technical/maintenance support and other related services are inclusive cost of the supply purchase.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
JA87HT8KP2M2
CAGE
22270
Vendor location
Bedford, MA
Contract
HT941024F0143 under V797D30108, delivery order
Obligated
$50,489.84
Actions
2 between August 29, 2024 and May 21, 2025
Competition
Full and Open Competition, 1 offer received
Described as
Cost Per Reportable Result Coagulation Analyzer at Naval Hospital Twentynine Palms
Match
solicitation number HT941024F0143 was reused as the contract number; same awarding office HT9410 (high confidence)
UEI
JA87HT8KP2M2
CAGE
22270
Vendor location
Bedford, MA
Contract
V797D30108
Obligated
$0.00, potential $68,095,988
Actions
7 between March 13, 2024 and February 3, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
Option to Extend
Match
award number V797D30108 equals the contract number; awarding office not confirmed (medium confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 29, 2024

    Award notice

    Awarded to WERFEN USA LLC Bedford for $50,490. SAM.gov, notice a776ad6b16054fbab88cf2d93e4c9bf7

Points of contact